These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34034646)

  • 1. Comparison study of differential abundance testing methods using two large Parkinson disease gut microbiome datasets derived from 16S amplicon sequencing.
    Wallen ZD
    BMC Bioinformatics; 2021 May; 22(1):265. PubMed ID: 34034646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
    Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
    Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-cohort study on the association between the gut microbiota and bone density, microarchitecture, and strength.
    Okoro PC; Orwoll ES; Huttenhower C; Morgan X; Kuntz TM; McIver LJ; Dufour AB; Bouxsein ML; Langsetmo L; Farsijani S; Kado DM; Pacifici R; Sahni S; Kiel DP
    Front Endocrinol (Lausanne); 2023; 14():1237727. PubMed ID: 37810879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of Taxonomic and Functional Gut Microbiota Profiles in Relation to Seroconversion of Thyroid Peroxidase Antibodies in Euthyroid Participants.
    Fenneman AC; Boulund U; Collard D; Galenkamp H; Zwinderman AH; van den Born BH; van der Spek AH; Fliers E; Rampanelli E; Blaser MJ; Nieuwdorp M
    Thyroid; 2024 Jan; 34(1):101-111. PubMed ID: 38010921
    [No Abstract]   [Full Text] [Related]  

  • 5. Large-scale benchmarking reveals false discoveries and count transformation sensitivity in 16S rRNA gene amplicon data analysis methods used in microbiome studies.
    Thorsen J; Brejnrod A; Mortensen M; Rasmussen MA; Stokholm J; Al-Soud WA; Sørensen S; Bisgaard H; Waage J
    Microbiome; 2016 Nov; 4(1):62. PubMed ID: 27884206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A realistic benchmark for differential abundance testing and confounder adjustment in human microbiome studies.
    Wirbel J; Essex M; Forslund SK; Zeller G
    Genome Biol; 2024 Sep; 25(1):247. PubMed ID: 39322959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of sequencing platforms and bioinformatics pipelines for compositional analysis of the gut microbiome.
    Allali I; Arnold JW; Roach J; Cadenas MB; Butz N; Hassan HM; Koci M; Ballou A; Mendoza M; Ali R; Azcarate-Peril MA
    BMC Microbiol; 2017 Sep; 17(1):194. PubMed ID: 28903732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Much ado about nothing? Off-target amplification can lead to false-positive bacterial brain microbiome detection in healthy and Parkinson's disease individuals.
    Bedarf JR; Beraza N; Khazneh H; Özkurt E; Baker D; Borger V; Wüllner U; Hildebrand F
    Microbiome; 2021 Mar; 9(1):75. PubMed ID: 33771222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota in patients with Parkinson's disease in southern China.
    Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
    Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
    Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
    Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
    [No Abstract]   [Full Text] [Related]  

  • 11. Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review.
    Boertien JM; Pereira PAB; Aho VTE; Scheperjans F
    J Parkinsons Dis; 2019; 9(s2):S297-S312. PubMed ID: 31498131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups.
    West KA; Yin X; Rutherford EM; Wee B; Choi J; Chrisman BS; Dunlap KL; Hannibal RL; Hartono W; Lin M; Raack E; Sabino K; Wu Y; Wall DP; David MM; Dabbagh K; DeSantis TZ; Iwai S
    Sci Rep; 2022 Oct; 12(1):17034. PubMed ID: 36220843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation and differential abundance analysis of microbiome data incorporating phylogeny.
    Zhou C; Zhao H; Wang T
    Bioinformatics; 2021 Dec; 37(24):4652-4660. PubMed ID: 34302462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogeny- and Abundance-Based Metrics Allow for the Consistent Comparison of Core Gut Microbiome Diversity Indices Across Host Species.
    Risely A; Gillingham MAF; Béchet A; Brändel S; Heni AC; Heurich M; Menke S; Manser MB; Tschapka M; Wasimuddin ; Sommer S
    Front Microbiol; 2021; 12():659918. PubMed ID: 34046023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling.
    Lau JT; Whelan FJ; Herath I; Lee CH; Collins SM; Bercik P; Surette MG
    Genome Med; 2016 Jul; 8(1):72. PubMed ID: 27363992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved detection of disease-associated gut microbes using 16S sequence-based biomarkers.
    Chrisman BS; Paskov KM; Stockham N; Jung JY; Varma M; Washington PY; Tataru C; Iwai S; DeSantis TZ; David M; Wall DP
    BMC Bioinformatics; 2021 Oct; 22(1):509. PubMed ID: 34666677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization and microbial differential abundance strategies depend upon data characteristics.
    Weiss S; Xu ZZ; Peddada S; Amir A; Bittinger K; Gonzalez A; Lozupone C; Zaneveld JR; Vázquez-Baeza Y; Birmingham A; Hyde ER; Knight R
    Microbiome; 2017 Mar; 5(1):27. PubMed ID: 28253908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benchmark of 16S rRNA gene amplicon sequencing using Japanese gut microbiome data from the V1-V2 and V3-V4 primer sets.
    Kameoka S; Motooka D; Watanabe S; Kubo R; Jung N; Midorikawa Y; Shinozaki NO; Sawai Y; Takeda AK; Nakamura S
    BMC Genomics; 2021 Jul; 22(1):527. PubMed ID: 34246242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of gut microbiota associated with clinical parameters in intrahepatic cholestasis of pregnancy.
    Li R; Chen X; Liu Z; Chen Y; Liu C; Ye L; Xiao L; Yang Z; He J; Wang WJ; Qi H
    BMC Gastroenterol; 2020 Nov; 20(1):395. PubMed ID: 33225888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Features of gut microbiota in patients with idiopathic Parkinson's disease].
    Li Y; Li RX; Du YT; Xu XJ; Xue Y; Gao D; Gao T; Sheng Z; Zhang LY; Tuo HZ
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1017-1022. PubMed ID: 32294860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.